The HEPLISAV-B brand, founded in 2013 (United States), is part of our Top Web Popularity Drug Manufacturers, from 5 sister brands and 4958 competing brands. The HEPLISAV-B brand is owned by Dynavax Technologies Co., a company listed in New York. The sector of HEPLISAV-B is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Dynavax Technologies Co.
(HEPLISAV-B)
over 5 years*
USD 18.68